Home > Financial Ratios > ALEMBIC

ALEMBIC
Core EBITDA Growth

    Back to All Ratios
ALEMBIC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

ALEMBIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 51.036.731.44383.10-77.92

What is the latest Core EBITDA Growth ratio of ALEMBIC ?

The latest Core EBITDA Growth ratio of ALEMBIC is 51.03 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202551.03
Mar20246.73
Mar20231.44
Mar2022383.10
Mar2021-77.92

How is Core EBITDA Growth of ALEMBIC Trending?

Years Core EBITDA Growth % Change
Mar2025 51.03
658.25
Mar2024 6.73
367.36
Mar2023 1.44
-99.62
Mar2022 383.1
Positive
Mar2021 -77.92 -

Other Financial Ratios of ALEMBIC


Compare Core EBITDA Growth ratio of peers of ALEMBIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC ₹2,569.0 Cr 3.8% 2% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


ALEMBIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC

3.8%

2%

-11.6%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses